Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 1:10 AM
NCT ID:
NCT06274593
Eligibility Criteria:
Inclusion Criteria:
* Men and women aged 18 and over
* Patient with glaucoma followed in the ophthalmology department of Nantes University Hospital
* mean visual field deficit (MD) \>10dB
Exclusion Criteria:
* Retinal vascular pathology (moderate to severe non-proliferative diabetic retinopathy, complicated diabetic retinopathy, OVCR/OBVR, OACR/OBAR, NOIAA...) Non-glaucomatous optic neuropathy, neurological pathology leading to visual field deficit (stroke with HLH, quadranopsia, chiasmatic Sd...)
* PPR (retinal PanPhotocoagulation), retinal cerclage
* Retinal pathology leading to visual field impairment (e.g. retinitis pigmentosa)
* AMD and other macular pathologies that can lead to central visual field deficits
* Significant environmental disorders impairing retinal imaging (e.g. active uveitis, dense cataract)
* Loss of fixation point preventing visual field formation Pregnant or breast-feeding women
* Protected adults under guardianship or curatorship
* with unreliable visual fields (false positives and false negatives \> 33%)
* with an uninterpretable OCTrnfl or OCTa (artifact, low quality score)
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06274593
Study Brief:
Protocol Section:
NCT06274593